IP Library Granted Patent US 10,420,636
Granted Patent B2
US 10,420,636 · App. 11/500,697 · Granted Sep 24, 2019

Stent graft devices having collagen coating

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,420,636
App. No.
11/500,697
Granted
Sep 24, 2019
Kind
B2
Abstract

Described are stent graft devices and methods for their preparation and use. Expandable stent graft devices of the invention include inner and/or outer coverings uniquely applied and associated with surfaces of the stent. In certain described embodiments, bioremodelable materials such as ECM materials are vacuum pressed onto and/or around elements of a stent in the manufacture of a stent graft device.

Claims (45)

1. A unitary, implantable stent graft device, comprising:

a unitary graft body having an expanded configuration for deployment, and a collapsed configuration for delivery, said unitary graft body in said expanded configuration including:

(i) a first graft segment defining a first inner lumen having a first diameter, the first graft segment having a first end;

(ii) a second graft segment and a third graft segment branching from the first end of the first graft segment, the second graft segment defining a second inner lumen having a second diameter and the third graft segment defining a third inner lumen having a third diameter, wherein the second inner lumen and third inner lumen are in fluid communication with the first inner lumen, and wherein the second diameter and the third diameter are smaller than the first diameter;

(iii) a plurality of discrete, spaced radially expandable stents positioned in said first graft segment;

(iv) an exterior lyophilized collagenous covering situated to the exterior of said stents, said exterior lyophilized collagenous covering being comprised of an extracellular matrix material retaining growth factors from a source tissue for the extracellular matrix material, said exterior lyophilized collagenous covering promoting cellular invasion and ingrowth when implanted, and said exterior lyophilized collagenous covering forming a first continuous circumferential tube of material surrounding the exterior of said stents, the first continuous circumferential tube of material defining a continuous circumferential outer surface of said first graft segment;

(v) an interior lyophilized collagenous covering situated to the interior of said stents, said interior lyophilized collagenous covering being comprised of an extracellular matrix material retaining growth factors from a source tissue for the extracellular matrix material, said interior lyophilized collagenous covering being a compressible material that includes an inwardly facing surface and an outwardly facing surface, said interior lyophilized collagenous covering promoting cellular invasion and ingrowth when implanted, and said interior lyophilized collagenous covering forming a second continuous circumferential tube of material surrounding the interior of said stents, the second continuous circumferential tube of material defining a continuous circumferential inner surface of said first graft segment and having been dehydrothermally bonded to said exterior lyophilized collagenous covering in the absence of other bonding agents;

(vi) said exterior lyophilized collagenous covering having inwardly facing surface regions that face toward and are bonded to the outwardly facing surface of said interior lyophilized collagenous covering which includes bonding in areas between adjacent stents of said plurality of stents so as to entrap the stents between said first continuous circumferential tube of material and said second continuous circumferential tube of material;

(vii) wherein strut elements of said stents are in contact with the outwardly facing surface of the interior lyophilized collagenous covering; and

(viii) wherein the strut elements of the stents are compressed into the interior lyophilized collagenous covering such that said outwardly facing surface of said interior lyophilized collagenous covering has regions locally contoured to the strut elements, such that a wall thickness of said interior lyophilized collagenous covering is less where said interior lyophilized collagenous covering passes over the strut elements as compared to adjacent regions of the interior lyophilized collagenous covering occurring between the strut elements, and further such that the inwardly facing surface of the interior lyophilized collagenous covering has a smooth contour lacking protuberances in regions where the interior lyophilized collagenous covering passes over and between strut elements of the stents.

2. The stent graft device of claim 1 , wherein said exterior lyophilized collagenous covering and said interior lyophilized collagenous covering have been provided by vacuum pressing an exterior collagenous covering material and an interior collagenous covering material followed by hydration and lyophilization of the exterior collagenous covering material and the interior collagenous covering material.

3. The stent graft device of claim 2 , wherein said growth factors include basic fibroblast growth factor.

4. The stent graft device of claim 3 , wherein said extracellular matrix material comprises submucosa.

5. The stent graft device of claim 1 , wherein at least one of said exterior lyophilized collagenous covering and interior lyophilized collagenous covering includes a multilaminate construct.

6. The stent graft device of claim 5 , wherein each of said exterior lyophilized collagenous covering and interior lyophilized collagenous covering includes a multilaminate construct formed of multiple covering material pieces.

7. The stent graft device of claim 6 , wherein pieces of said multiple covering material pieces are arranged to contact respective spaced stents of said plurality of stents and to have ends that overlap one another in a region spanning between the respective spaced stents.

8. The stent graft device of claim 1 , wherein said exterior lyophilized collagenous covering and interior lyophilized collagenous covering form a unitary collagenous structure embedding the stents and extending along the first graft segment, second graft segment and third graft segment.

9. The stent graft device of claim 1 , wherein an outwardly-facing surface of the exterior lyophilized collagenous covering has protuberances in regions where the exterior lyophilized collagenous covering passes over strut elements of the stents.

10. The stent graft device of claim 1 , which is a vascular stent graft device.

11. The stent graft device of claim 1 , wherein the exterior lyophilized collagenous covering and interior lyophilized collagenous covering are bonded to one another over substantially all contacting areas of the two coverings such that the relation between the expandable stents and the bonded exterior lyophilized collagenous covering is fixed.

12. The stent graft device of claim 1 , wherein an outwardly-facing exterior surface of the exterior lyophilized collagenous covering has a smooth contour lacking protuberances in regions where the exterior lyophilized collagenous covering passes over and spans between strut elements of the stents.

13. A stented graft construct, comprising:

a unitary graft body having an expanded configuration for deployment, and a collapsed configuration for delivery, said unitary graft body in said expanded configuration including:

(i) a plurality of discrete, spaced stents spaced to provide openings between the stents; and

(ii) said discrete, spaced stents interconnected to one another by inner and outer layers of a bioremodelable covering material that promote cellular invasion and ingrowth when implanted, wherein the inner and outer layers of bioremodelable covering material are each comprised of an extracellular matrix material retaining growth factors from a source tissue for the extracellular matrix material, wherein the inner and outer layers of bioremodelable covering material each form a continuous circumferential tube of material, wherein the inner and outer layers of bioremodelable covering material are sufficiently dehydrothermally bonded to one another in the absence of other bonding agents including through said openings to entrap the stents and form a stable, unitary stented graft construct for subsequent implantation in a patient, and wherein said inner layer of bioremodelable covering material is a compressible material that includes an inwardly facing surface and an outwardly facing surface, said outwardly facing surface being in contact with strut elements of said stents that are compressed into the inner layer of bioremodelable covering material such that said outwardly facing surface is contoured to the strut elements, such that a thickness of said inner layer of bioremodelable covering material is less where said inner layer of bioremodelable covering material passes over the strut elements as compared to adjacent regions of the inner layer of bioremodelable covering material that span between the strut elements, and further such that said inwardly facing surface has a smooth contour lacking protuberances in regions where said inner layer of bioremodelable covering material passes over and spans between the strut elements of said stents.

14. The stented graft construct of claim 13 , wherein said inner and outer layers each include a multilaminate construct, wherein the outer layer is provided by submucosal extracellular matrix material, and wherein the inner layer is provided by non-submucosal extracellular matrix material.

15. The stented graft construct of claim 14 , wherein said multilaminate construct includes a plurality of bonded extracellular matrix layers.

16. The stented graft construct of claim 13 , wherein said stents are radially expandable stents.

17. The stented graft construct of claim 13 , wherein the inner and outer layers of bioremodelable covering material are lyophilized and have been provided by bonding an inner layer of bioremodelable covering material and an outer layer of bioremodelable covering material to one another under vacuum pressing conditions followed by hydration and lyophilization of the inner layer of bioremodelable covering material and the outer layer of bioremodelable covering material.

18. The stented graft construct of claim 17 , wherein said growth factors include basic fibroblast growth factor.

19. The stented graft construct of claim 18 , wherein the bioremodelable covering material comprises submucosa.

20. The stented graft construct of claim 13 , wherein the inner layer of bioremodelable covering and outer layer of bioremodelable covering material are bonded to one another over substantially all contacting areas of the two coverings such that the relation between the stents and the bonded inner layer of bioremodelable covering material and outer layer of bioremodelable covering material is fixed.

21. The stented graft construct of claim 13 , wherein an outwardly-facing exterior surface of the outer layer of bioremodelable covering material has a smooth contour lacking protuberances in regions where the outer layer of bioremodelable covering material passes over and spans between strut elements of the stents.

22. The stented graft construct of claim 13 , comprising a graft body including a first graft segment defining a first inner lumen, the first graft segment having a first end, with said plurality of discrete, spaced stents positioned in said first graft segment; and

the graft body also including a second graft segment and a third graft segment each branching from the first end of the first graft segment, the second graft segment defining a second inner lumen and the third graft segment defining a third inner lumen, wherein the second inner lumen and third inner lumen are in fluid communication with the first inner lumen.

23. A stented graft construct, comprising:

a unitary graft body having an expanded configuration for deployment, and a collapsed configuration for delivery, said unitary graft body in said expanded configuration including:

(i) a plurality of discrete, spaced, serpentine stent elements in succession with openings between successive stent elements;

(ii) said discrete, spaced stent elements interconnected to one another by being entrapped between inner and outer layers of a bioremodelable covering material that promotes cellular invasion and ingrowth when implanted, wherein the inner and outer layers of bioremodelable covering material are each comprised of an extracellular matrix material retaining growth factors from a source tissue for the extracellular matrix material, said inner and outer layers each forming a continuous circumferential tube of material, said inner and outer layers being dehydrothermally bonded to one another in the absence of other bonding agents including through said openings so as to provide a generally fixed association of said stent elements with the bioremodelable covering material, wherein the inner and outer layers are sufficiently bonded to one another to form a stable, unitary stented graft construct for subsequent implantation in a patient; and

(iii) wherein said inner layer of bioremodelable covering material is a compressible material that includes an inwardly facing surface and an outwardly facing surface, said outwardly facing surface being in contact with strut elements of said stent elements that are compressed into the inner layer of bioremodelable covering material such that said outwardly facing surface is contoured to said strut elements, such that said inner layer of bioremodelable covering material has a wall thickness that is less where said inner layer of bioremodelable covering material passes over the strut elements as compared to adjacent regions of the inner layer of bioremodelable covering material that span between the strut elements, and further such that said inwardly facing surface has a smooth contour lacking protuberances in regions where said inner layer of bioremodelable covering material passes over and spans between the strut elements of said stent elements.

24. The stented graft construct of claim 23 , wherein said inner and outer layers each includes a multilaminate construct.

25. The stented graft construct of claim 23 , wherein said inner and outer layers are dehydrothermally bonded to one another by lyophilizing said inner and outer layers in contact with one another.

26. The stented graft construct of claim 23 , wherein the inner and outer layers of bioremodelable covering material are lyophilized and have been provided by bonding an inner layer of bioremodelable covering material and an outer layer of bioremodelable covering material to one another under vacuum pressing conditions followed by hydration and lyophilization of the inner layer of bioremodelable covering material and the outer layer of bioremodelable covering material.

27. The stented graft construct of claim 23 , wherein the outer layer of bioremodelable covering material and inner layer of bioremodelable covering material are bonded to one another over substantially all contacting areas of the two coverings such that the relation between the stent elements and the bonded outer layer of bioremodelable covering material and inner layer of bioremodelable covering material is fixed.

28. The stented graft construct of claim 23 , wherein an outwardly-facing exterior surface of the outer layer of bioremodelable covering material has protuberances in regions where the outer layer of bioremodelable covering material passes over strut elements of the stents elements.

Assignments (6)
SECURITY INTEREST Recorded Sep 25, 2025
From: RTI SURGICAL, INC.; COOK BIOTECH INCORPORATED; TISSX, LLC
To: GOLUB CAPITAL MARKETS LLC, AS COLLATERAL AGENT
Reel/Frame 072924/0721 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Sep 25, 2025
From: ARES CAPITAL CORPORATION
To: COOK BIOTECH INCORPORATED
Reel/Frame 072938/0231 →
SECURITY INTEREST Recorded Apr 3, 2024
From: COOK BIOTECH INCORPORATED
To: ARES CAPITAL CORPORATION, AS SECURITY AGENT
Reel/Frame 067001/0541 →
PATENT ASSIGNMENT AGREEMENT Recorded Feb 1, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: COOK BIOTECH INCORPORATED
Reel/Frame 066436/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2019
From: COOK BIOTECH INCORPORATED
To: COOK INCORPORATED
Reel/Frame 048072/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2019
From: COOK INCORPORATED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 048072/0516 →